Submissions from lilly.com

		Orforglipron Phase 3 trials results (lilly.com)
		2 points by stein1946 5 months ago \| past
		Lilly to Acquire Morphic for $3.2B (lilly.com)
		4 points by EhsanEtezad on July 8, 2024 \| past \| 1 comment
		Tirzepatide reduced sleep apnea severity in adults with sleep apnea and obesity (lilly.com)
		3 points by trevortheblack on April 17, 2024 \| past \| 1 comment
		FDA Approves Lilly's Zepbound (Tirzepatide) for Chronic Weight Management (lilly.com)
		50 points by openair18 on Nov 8, 2023 \| past \| 94 comments
		Tirzepatide shows total mean weight loss of 26.6% over 84 weeks (lilly.com)
		3 points by mmanfrin on Oct 16, 2023 \| past \| 1 comment
		New drug Donanemab Significantly Slowed Decline of Early Alzheimer's Disease (lilly.com)
		2 points by ortusdux on May 3, 2023 \| past \| 2 comments
		Lilly Cuts Insulin Prices by 70% and Caps Patient Insulin Costs at $35 per Month (lilly.com)
		4 points by FigurativeVoid on March 2, 2023 \| past
		Tirzepatide delivered up to 22.5% weight loss in obese or overweight adults (lilly.com)
		33 points by phnofive on Oct 16, 2022 \| past \| 21 comments
		Naming a New Drug During a Pandemic (lilly.com)
		2 points by alextheparrot on Dec 12, 2020 \| past